STOCK TITAN

DarioHealth Corp - DRIO STOCK NEWS

Welcome to our dedicated news page for DarioHealth (Ticker: DRIO), a resource for investors and traders seeking the latest updates and insights on DarioHealth.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DarioHealth's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DarioHealth's position in the market.

Rhea-AI Summary
DarioHealth Corp. announced research at the American Diabetes Association 83rd Scientific Sessions demonstrating significant reductions in HbA1c for Dario users compared to non-users. The study found statistically significant reductions in HbA1c compared to matched controls across real-world user data. Users with a baseline HbA1c greater than 9 points demonstrated the greatest improvement with a 2.3 point reduction in HbA1c in Dario users compared to a 1.8 point reduction for non-users.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.82%
Tags
none
-
Rhea-AI Summary
DarioHealth Corp. will participate in the Stifel 2023 Virtual Cross Sector Insight Conference on June 6-7, 2023. Rick Anderson, President of Dario, will give a company presentation on June 6 at 4:45 PM EST.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.34%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.32%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.98%
Tags
none
Rhea-AI Summary
DarioHealth Corp. to release Q1 2023 financial results on May 11 and host conference call and webcast at 8:30am ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.99%
Tags
conferences earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
none
DarioHealth Corp

Nasdaq:DRIO

DRIO Rankings

DRIO Stock Data

36.21M
23.92M
14.81%
29.43%
4.63%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
New York

About DRIO

DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform.